Chiesi USA is committed to developing and commercializing products that meet the needs of healthcare providers and their patients. We deliver our products and associated services to improve the treatment of patients.

We are also dedicated to investing in research and development initiatives that deliver value-added medical solutions in our current therapeutic areas as well as other therapeutic areas where the need exists.

Click here to view Full Prescribing Information for CLEVIPREX.

PP-CP-0310 V1.0

Contact Information

Enter to win one of our amazing door prizes.  Clinical Decision Making is giving away an Apple Watch Series 5 each day.  Visit each vendor and enter for more chances to win.  Only one entry per vendor page is allowed - invalid email address entries and duplicate entries will be deleted before the drawing each day.

CLEVIPREX® (clevidipine)

A ready-to-use I.V. calcium channel blocker with non-weight-based dosing that is independent of renal or hepatic function¹

Contact Us

Please enter your name.
Please enter a subject.
Please enter a valid phone number.
Please enter a message.

Our brochures


CLEVIPREX in Published Guidelines


CLEVIPREX Dosing and Administration Fact Sheet